149033-48-7—Key intermediate for fluorinated sugar synthesis and drug development

In contemporary medicinal chemistry and synthetic biology, fluorinated compounds are becoming core tools for optimizing the performance of drug molecules due to their unique physical and chemical properties. Among them, 2-acetamido-1,4,6-tri-O-acetyl-2,3-dideoxy-3-fluoroglucopyranose, as a type of precisely customized fluorinated sugar derivatives, not only demonstrates the molecular innovation brought about by the introduction of fluorine atoms, but also plays an indispensable role in the development of antibiotics, antiviral agents and targeted therapies. By fusing the biological compatibility of the sugar backbone with the highly reactive properties of fluorine atoms, this compound provides a key chemical building block for the design of next-generation therapeutic drugs, and is gradually promoting the field of medicine to become more efficient and precise.

Chemical Information

Chemical name: 2-acetamido-1,4,6-tri-O-acetyl-2,3-dideoxy-3-fluoroglucopyranose

Chemical formula: C14H20FNO8

Molecular weight: 349.31 g/mol

CAS number: 149033-48-7

Category: Fluorinated Compound

Structural features

The structure of this compound is based on multiple modifications of the glucose pyranose ring, which reflects the ability to finely regulate molecules in modern synthetic chemistry:

Fluorine atom substitution: introduce a fluorine atom into the 3-position carbon atom of the sugar ring to replace the original hydroxyl group. As the most electronegative element in the periodic table, fluorine can significantly change the molecular electron cloud distribution and enhance the stability and polarity of carbon-fluorine bonds, thus affecting the overall lipophilicity, metabolic resistance and target interaction. This substitution often reduces the rate of oxidative metabolism and prolongs the half-life of the drug.

Deoxygenation and protecting group strategy: Deoxygenation is achieved at positions 2 and 3 to simplify the sugar ring conformation, while acetoxy groups (-OAc) at positions 1, 4, and 6 serve as protective groups to ensure reaction selectivity during the synthesis process. Acetyl groups are easily introduced and removed, providing a flexible platform for subsequent functionalization such as glycosidic bond formation or amino modification.

Acetamido modification: Connecting acetamido (-NHAc) at position 2 simulates the structure of natural sugar amines and enhances the recognition ability of molecules and biological receptors (such as enzymes or transporters). This design is commonly seen in carbohydrate drugs to optimize cell permeability and binding specificity.

Overall, this structure combines the fluorination effect with protecting group chemistry to create a multifunctional intermediate with both stability and reactivity, laying the foundation for complex molecular assembly.

Main applications and advantages

Key intermediates in drug synthesis

In the development of antibiotics and anticancer drugs, fluorinated sugar units are widely used to enhance drug efficacy. For example, the compound can be used as a precursor for the synthesis of fluorinated nucleoside analogues, which can be further transformed to produce molecules with antiviral or antitumor activity. The introduction of fluorine atoms can simulate the transition state of natural sugars and inhibit sugar metabolism enzymes (such as glycosidases or kinases), thereby blocking pathogen replication or cancer cell proliferation. It shows high efficiency in the construction of kanamycin derivatives or fluorinated glucose analogs, which can help develop therapies against drug-resistant strains or specific targets.

Chemical probes and biological research tools

With the unique nuclear magnetic resonance (19F NMR) signal of fluorine atoms, this compound can be used to design molecular probes to track sugar metabolism pathways or enzyme kinetic processes in real time. In chemical biology, fluorinated sugar probes can penetrate cell membranes, mark glycoproteins or glycan structures, reveal disease-related glycosylation abnormalities, and provide new perspectives for the diagnosis of cancer or infectious diseases. In addition, acetyl protection allows controlled release of active sugar units and is suitable for the study of enzymatic reaction mechanisms.

Molecular platforms to optimize drug performance

Fluorination modification not only improves metabolic stability, but also improves oral bioavailability of drugs by adjusting lipophilic-hydrophilic balance. The compound's carbohydrate backbone ensures biological compatibility, while the combination of fluorine atoms and protecting groups gives it multifunctional derivatization potential. In peptide drug or oligosaccharide synthesis, it can be used as a modular unit to introduce fluorinated tags to enhance membrane permeability while reducing off-target effects. Compared with other fluorinated intermediates, its structural clarity supports high-throughput synthesis and structure-activity relationship analysis.

Potential applications in materials science and catalysis

In non-pharmaceutical fields, the compound's fluorination properties could be used to design functional materials such as glycosylated surface coatings or chiral catalysts. The introduction of fluorine atoms can change the interface properties of materials and enhance chemical resistance, showing value in the development of biosensors or delivery systems. Its synthetic route also provides a reference for green chemistry and promotes the application of fluorination strategies in sustainable manufacturing.

Conclusion

2-acetamido-1,4,6-tri-O-acetyl-2,3-dideoxy-3-fluoroglucopyranose represents a sophisticated advance in fluorinated carbohydrate chemistry, from basic synthesis to therapeutic innovation, and its versatility continues to push the boundaries of drug discovery. As the understanding of the biological effects of fluorine atoms deepens, the compound is expected to play a wider role in personalized medicine, new antibiotics and targeted delivery systems, providing chemical solutions to global health challenges. In the future, through interdisciplinary collaboration, these molecules may lead to safer and more efficient therapies and reshape the landscape of disease treatment.

The above information is provided by the editor of KASONS and is for scientific research only.